Medios AG: Constantijn van Rietschoten appointed Executive Board member for International Markets Berlin, May 6, 2024 – The Supervisory Board of Medios AG ("Medios") has appointed Constantijn van Rietschoten as member to the Company's Executive Board with effect from May 1, 2024. In his new role as Chief International Markets, van Rietschoten, who  [ … ]

Press release Medios achieves double-digit growth in 2023 – Positive outlook for 2024 Berlin, March 27, 2024 - Medios AG ("Medios"), the leading provider of specialty pharma solutions in Germany, once again grew strongly in the 2023 financial year. From January to December 2023, consolidated revenue increased by 10.8% to around €1.8 billion (prev [ … ]

Medios acquires Dutch market leader in pharmaceutical compounding servicesImportant first step in building the leading European Specialty Pharma platform – Mid-term targets to be reached already in 2025 Berlin, March 18, 2024 – Medios, the leading provider of Specialty Pharma Solutions in Germany, today announced the acquisition of Ceban Pharmaceu [ … ]

Press Release Medios AG: Supervisory Board extends contracts with members of the Executive Board Mi-Young Miehler and Christoph Prußeit Berlin, February 1, 2024 – The Supervisory Board of Medios AG ("Medios") has decided to extend the existing Executive Board contracts of Mi-Young Miehler (Chief Operating Officer / COO) and Christoph Prußeit (Chi [ … ]